Respiratory manifestations of malaria

Chest

Volumn 142, Issue 2, 2012, Pages 492-505

  Taylor, Walter R J ^a,b,c   Hanson, Josh ^d   Turner, Gareth D H ^a,b   White, Nicholas J ^a,b   Dondorp, Arjen M ^a,b  

^a MAHIDOL OXFORD TROPICAL MEDICINE RESEARCH UNIT   (Thailand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d CAIRNS BASE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ARTEMETHER; ARTESUNATE; CEPHALOSPORIN DERIVATIVE; DEXAMETHASONE; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; NITRIC OXIDE; QUININE; VASCULOTROPIN;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; AIRWAY OBSTRUCTION; ANAPHYLAXIS; ANEMIA; ARTIFICIAL VENTILATION; ASPIRATION PNEUMONIA; BACTEREMIA; BACTERIAL PNEUMONIA; BRAIN EDEMA; BRAIN MALARIA; CAPILLARY PERMEABILITY; CARDIOVASCULAR DISEASE; COUGHING; DISEASE SEVERITY; DRUG MEGADOSE; ENDOTHELIAL DYSFUNCTION; EXTRACORPOREAL OXYGENATION; FLUID RESUSCITATION; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; HYPERCAPNIA; HYPOGLYCEMIA; INTENSIVE CARE; INTRACRANIAL PRESSURE; LUNG EDEMA; MALARIA; MALARIA FALCIPARUM; METABOLIC ACIDOSIS; NONHUMAN; NONINVASIVE VENTILATION; PARASITE CLEARANCE; PATHOGENESIS; PLASMODIUM KNOWLESI MALARIA; PLASMODIUM VIVAX MALARIA; PREGNANT WOMAN; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY DISTRESS; RESPIRATORY TRACT DISEASE; REVIEW; TACHYPNEA; UNCONSCIOUSNESS;

EID: 84864799833     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-2655     Document Type: Article

References (117)

1. Daneshvar C, Davis TM, Cox-Singh J, et al. Clinical and laboratory features of human Plasmodium knowlesi infection. Clin Infect Dis. 2009;49(6):852-860.
2. Guerra CA, Gikandi PW, Tatem AJ, et al. The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide. PLoS Med. 2008;5(2):e38.
3. Hay SI, Guerra CA, Gething PW, et al. A world malaria map: Plasmodium falciparum endemicity in 2007. PLoS Med. 2009;6(3):e1000048.
4. Guerra CA, Howes RE, Patil AP, et al. The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Negl Trop Dis. 2010;4(8):e774.
5. World Health Organization. World Malaria Report 2011. Geneva, Switzerland: World Health Organization; 2011.
6. Loutan L. Malaria: still a threat to travellers. Int J Antimicrob Agents. 2003;21(2):158-163.
7. Mali S, Steele S, Slutsker L, Arguin PM; Centers for Disease Control and Prevention (CDC). Malaria surveillance - United States, 2006. MMWR Surveill Summ. 2008;57(5):24-39.
8. Mali S, Steele S, Slutsker L, Arguin PM; Centers for Disease Control and Prevention (CDC). Malaria surveillance - United States, 2008. MMWR Surveill Summ. 2010;59(7):1-15.
9. Dondorp AM, Pongponratn E, White NJ. Reduced microcirculatory flow in severe falciparum malaria: pathophysiology and electron-microscopic pathology. Acta Trop. 2004;89(3):309-317.
10. Dondorp A, Nosten F, Stepniewska K, Day N, White N; South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet. 2005;366(9487):717-725.
11. Dondorp AM, Fanello CI, Hendriksen IC, et al; AQUAMAT group. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet. 2010;376(9753):1647-1657.
12. Sahu S, Mohanty NK, Rath J, Patnaik SB. Spectrum of malaria complications in an intensive care unit. Singapore Med J. 2010;51(3):226-229.
13. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg. 2000;94(suppl 1):S1-S90.
14. Blumberg L, Lee RP, Lipman J, Beards S. Predictors of mortality in severe malaria: a two year experience in a non-endemic area. Anaesth Intensive Care. 1996;24(2):217-223.
15. Krishnan A, Karnad DR. Severe falciparum malaria: an important cause of multiple organ failure in Indian intensive care unit patients. Crit Care Med. 2003;31(9):2278-2284.
16. Day NP, Phu NH, Mai NT, et al. The pathophysiologic and prognostic significance of acidosis in severe adult malaria. Crit Care Med. 2000;28(6):1833-1840.
17. Dondorp AM, Chau TT, Phu NH, et al. Unidentified acids of strong prognostic significance in severe malaria. Crit Care Med. 2004;32(8):1683-1688.
18. Hanson J, Lee SJ, Mohanty S, et al. A simple score to predict the outcome of severe malaria in adults. Clin Infect Dis. 2010;50(5):679-685.
19. Dondorp AM, Lee SJ, Faiz MA, et al. The relationship between age and the manifestations of and mortality associated with severe malaria. Clin Infect Dis. 2008;47(2):151-157.
20. Chotivanich K, Udomsangpetch R, Suwanarusk R, et al. Plasmodium vivax adherence to placental glycosaminoglycans. PLoS One. 2012;7:e34509.
21. Carvalho BO, Lopes SC, Nogueira PA, et al. On the cytoadhesion of Plasmodium vivax-infected erythrocytes. J Infect Dis. 2010;202(4):638-647.
22. Anstey NM, Handojo T, Pain MC, et al. Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation. J Infect Dis. 2007;195(4):589-596.
23. Tjitra E, Anstey NM, Sugiarto P, et al. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med. 2008;5(6):e128.
24. Genton B, D'Acremont V, Rare L, et al. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med. 2008;5(6):e127.
25. Barcus MJ, Basri H, Picarima H, et al. Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua. Am J Trop Med Hyg. 2007;77(5):984-991.
26. Kochar DK, Das A, Kochar SK, et al. Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India. Am J Trop Med Hyg. 2009;80(2):194-198.
27. Price L, Planche T, Rayner C, Krishna S. Acute respiratory distress syndrome in Plasmodium vivax malaria: case report and review of the literature. Trans R Soc Trop Med Hyg. 2007;101(7):655-659.
28. Cox-Singh J, Hiu J, Lucas SB, et al. Severe malaria - a case of fatal Plasmodium knowlesi infection with post-mortem findings: a case report. Malar J. 2010;9:10.
29. Luxemburger C, Nosten F, Kyle DE, Kiricharoen L, Chongsuphajaisiddhi T, White NJ. Clinical features cannot predict a diagnosis of malaria or differentiate the infecting species in children living in an area of low transmission. Trans R Soc Trop Med Hyg. 1998;92(1):45-49.
30. Anstey NM, Jacups SP, Cain T, et al. Pulmonary manifestations of uncomplicated falciparum and vivax malaria: cough, small airways obstruction, impaired gas transfer, and increased pulmonary phagocytic activity. J Infect Dis. 2002;185(9):1326-1334.
31. Hovette P, Touze JE, Laroche R. Pulmonary manifestations of malaria [in French]. Bull Soc Pathol Exot. 1990;83(4):479-486.
32. Rajput R, Singh H, Singh S, Meena, Tiwari UC. Pulmonary manifestations in malaria. J Indian Med Assoc. 2000;98(10):612-614.
33. Gozal D. The incidence of pulmonary manifestations during Plasmodium falciparum malaria in non immune subjects. Trop Med Parasitol. 1992;43(1):6-8.
34. Maguire GP, Handojo T, Pain MC, et al. Lung injury in uncomplicated and severe falciparum malaria: a longitudinal study in Papua, Indonesia. J Infect Dis. 2005;192(11):1966-1974.
35. Bruneel F, Tubach F, Corne P, et al; Severe Imported Malaria in Adults (SIMA) Study Group. Severe imported falciparum malaria: a cohort study in 400 critically ill adults. PLoS ONE. 2010;5(10):e13236.
36. Tran TH, Day NP, Nguyen HP, et al. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med. 1996;335(2):76-83.
37. Kochar D, Kumawat BL, Karan S, Kochar SK, Agarwal RP. Severe and complicated malaria in Bikaner (Rajasthan), western India. Southeast Asian J Trop Med Public Health. 1997;28(2):259-267.
38. Phu NH, Tuan PQ, Day N, et al. Randomized controlled trial of artesunate or artemether in Vietnamese adults with severe falciparum malaria. Malar J. 2010;9:97.
39. Robinson T, Mosha F, Grainge M, Madeley R. Indicators of mortality in African adults with malaria. Trans R Soc Trop Med Hyg. 2006;100(8):719-724.
40. Banzal S, Ayoola EA, El Sammani EE, Gadour MO, Jain AK. The clinical pattern and complications of severe malaria in the Gizan region of Saudi Arabia. Ann Saudi Med. 1999;19(4):378-380.
41. Kochar DK, Kochar SK, Agrawal RP, et al. The changing spectrum of severe falciparum malaria: a clinical study from Bikaner (northwest India). J Vector Borne Dis. 2006;43(3):104-108.
42. Murthy GL, Sahay RK, Srinivasan VR, Upadhaya AC, Shantaram V, Gayatri K. Clinical profile of falciparum malaria in a tertiary care hospital. J Indian Med Assoc. 2000;98(4):160-162., 169.
43. Jain V, Nagpal AC, Joel PK, et al. Burden of cerebral malaria in central India (2004-2007). Am J Trop Med Hyg. 2008;79(4):636-642.
44. Newton PN, Angus BJ, Chierakul W, et al. Randomized comparison of artesunate and quinine in the treatment of severe falciparum malaria. Clin Infect Dis. 2003;37(1):7-16.
45. William T, Menon J, Rajahram G, et al. Severe Plasmodium knowlesi malaria in a tertiary care hospital, Sabah, Malaysia. Emerg Infect Dis. 2011;17(7):1248-1255.
46. Marsh K, Forster D, Waruiru C, et al. Indicators of life-threatening malaria in African children. N Engl J Med. 1995;332(21):1399-1404.
47. Gérardin P, Rogier C, Ka AS, Jouvencel P, Diatta B, Imbert P. Outcome of life-threatening malaria in African children requiring endotracheal intubation. Malar J. 2007;6:51.
48. Kochar DK, Tanwar GS, Khatri PC, et al. Clinical features of children hospitalized with malaria - a study from Bikaner, northwest India. Am J Trop Med Hyg. 2010;83(5):981-989.
49. von Seidlein L, Olaosebikan R, Hendriksen IC, et al. Predicting the clinical outcome of severe falciparum malaria in African children: findings from a large randomized trial. Clin Infect Dis. 2012;54(8):1080-1090.
50. Bernard GR, Artigas A, Brigham KL, et al; Consensus Committee. Report of the American-European Consensus conference on acute respiratory distress syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination. J Crit Care. 1994;9(1):72-81.
51. Deaton JG. Fatal pulmonary edema as a complication of acute falciparum malaria. Am J Trop Med Hyg. 1970;19(2):196-201.
52. Punyagupta S, Srichaikul T, Nitiyanant P, Petchclai B. Acute pulmonary insufficiency in falciparum malaria: summary of 12 cases with evidence of disseminated intravascular coagulation. Am J Trop Med Hyg. 1974;23(4):551-559.
53. Valecha N, Pinto RG, Turner GD, et al. Histopathology of fatal respiratory distress caused by Plasmodium vivax malaria. Am J Trop Med Hyg. 2009;81(5):758-762.
54. Sheehy TW, Reba RC. Complications of falciparum malaria and their treatment. Ann Intern Med. 1967;66(4):807-809.
55. Mohan A, Sharma SK, Bollineni S. Acute lung injury and acute respiratory distress syndrome in malaria. J Vector Borne Dis. 2008;45(3):179-193.
56. Agarwal R, Nath A, Gupta D. Noninvasive ventilation in Plasmodium vivax related ALI/ARDS. Intern Med. 2007;46(24):2007-2011.
57. Maguire JD, Fenton ME, Susanti AI, Walker JB. Plasmodium vivax -associated acute respiratory distress syndrome after extended travel in Afghanistan. Travel Med Infect Dis. 2007;5(5):301-305.
58. Pukrittayakamee S, Chantra A, Vanijanonta S, White NJ. Pulmonary oedema in vivax malaria. Trans R Soc Trop Med Hyg. 1998;92(4):421-422.
59. Kotwal RS, Wenzel RB, Sterling RA, Porter WD, Jordan NN, Petruccelli BP. An outbreak of malaria in US Army Rangers returning from Afghanistan. JAMA. 2005;293(2):212-216.
60. Kochar DK, Saxena V, Singh N, Kochar SK, Kumar SV, Das A. Plasmodium vivax malaria. Emerg Infect Dis. 2005;11(1):132-134.
61. Lee EY, Maguire JH. Acute pulmonary edema complicating ovale malaria. Clin Infect Dis. 1999;29(3):697-698.
62. Descheemaeker PN, Mira JP, Bruneel F, et al. Near-fatal multiple organ dysfunction syndrome induced by Plasmodium malariae. Emerg Infect Dis. 2009;15(5):832-834.
63. Dafallah SE, El-Agib FH, Bushra GO. Maternal mortality in a teaching hospital in Sudan. Saudi Med J. 2003;24(4):369-372.
64. Looareesuwan S, Phillips RE, White NJ, et al. Quinine and severe falciparum malaria in late pregnancy. Lancet. 1985;2(8445):4-8.
65. Baud M, Bauchet E, Poilane I, Levacher S, Pourriat JL. Acute respiratory distress syndrome due to falciparum malaria in a pregnant woman. Intensive Care Med. 1997;23(7):787-789.
66. Adam I, Elbashir MI. Maternal death due to severe pulmonary oedema caused by falciparum malaria: a case report. East Mediterr Health J. 2004;10(4-5):685-687.
67. Adam I, Mirghani OA, Saed OK, et al. Quinine therapy in severe Plasmodium falciparum malaria during pregnancy in Sudan. East Mediterr Health J. 2004;10(1-2):159-166.
68. Adam I, Ali DM, Elbashir MI. Manifestations of falciparum malaria in pregnant women of Eastern Sudan. Saudi Med J. 2004;25(12):1947-1950.
69. Kochar DK, Thanvi I, Joshi A, Shubhakaran, Agarwal N, Jain N. Mortality trends in falciparum malaria - effect of gender difference and pregnancy. J Assoc Physicians India. 1999;47(8):774-778.
70. Shimabukuro DW, Sawa T, Gropper MA. Injury and repair in lung and airways. Crit Care Med. 2003;31(suppl 8):S524-S531.
71. Schultz MJ, Haitsma JJ, Zhang H, Slutsky AS. Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia - a review. Crit Care Med. 2006;34(3):871-877.
72. Day NP, Hien TT, Schollaardt T, et al. The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J Infect Dis. 1999;180(4):1288-1297.
73. Yeo TW, Lampah DA, Gitawati R, et al. Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria. J Exp Med. 2007;204(11):2693-2704.
74. Zwissler B, Kemming G, Habler O, et al. Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome. Am J Respir Crit Care Med. 1996;154(6 pt 1):1671-1677.
75. Yeo TW, Lampah DA, Tjitra E, et al. Increased asymmetric dimethylarginine in severe falciparum malaria: association with impaired nitric oxide bioavailability and fatal outcome. PLoS Pathog. 2010;6(4):e1000868.
76. Epiphanio S, Campos MG, Pamplona A, et al. VEGF promotes malaria-associated acute lung injury in mice. PLoS Pathog. 2010;6(5):e1000916.
77. Yeo TW, Lampah DA, Gitawati R, et al. Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. Proc Natl Acad Sci U S A. 2008;105(44):17097-17102.
78. Jain V, Armah HB, Tongren JE, et al. Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malar J. 2008;7:83.
79. Spitz S. The pathology of acute falciparum malaria. Mil Surg. 1946;99(5):555-572.
80. Duarte MI, Corbett CE, Boulos M, Amato Neto V. Ultrastructure of the lung in falciparum malaria. Am J Trop Med Hyg. 1985;34(1):31-35.
81. Corbett CE, Duarte MI, Lancellotti CL, Silva MA, Andrade Júnior HF. Cytoadherence in human falciparum malaria as a cause of respiratory distress. J Trop Med Hyg. 1989;92(2):112-120.
82. Franke-Fayard B, Janse CJ, Cunha-Rodrigues M, et al. Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration. Proc Natl Acad Sci U S A. 2005;102(32):11468-11473.
83. Lovegrove FE, Gharib SA, Peña-Castillo L, et al. Parasite burden and CD36-mediated sequestration are determinants of acute lung injury in an experimental malaria model. PLoS Pathog. 2008;4(5):e1000068.
84. Ozwara H, Langermans JA, Maamun J, et al. Experimental infection of the olive baboon (Paplio anubis) with Plasmodium knowlesi: severe disease accompanied by cerebral involvement. Am J Trop Med Hyg. 2003;69(2):188-194.
85. Aikawa M, Brown A, Smith CD, et al. A primate model for human cerebral malaria: Plasmodium coatneyi-infected rhesus monkeys. Am J Trop Med Hyg. 1992;46(4):391-397.
86. Taylor WR, White NJ. Antimalarial drug toxicity: a review. Drug Saf. 2004;27(1):25-61.
87. Maude RJ, Plewes K, Faiz MA, et al. Does artesunate prolong the electrocardiograph QT interval in patients with severe malaria? Am J Trop Med Hyg. 2009;80(1):126-132.
88. Hien TT, Davis TM, Chuong LV, et al. Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria. Antimicrob Agents Chemother. 2004;48(11):4234-4239.
89. Leonardi E, Gilvary G, White NJ, Nosten F. Severe allergic reactions to oral artesunate: a report of two cases. Trans R Soc Trop Med Hyg. 2001;95(2):182-183.
90. Warrell DA, Looareesuwan S, Warrell MJ, et al. Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients. N Engl J Med. 1982;306(6):313-319.
91. Hoffman SL, Rustama D, Punjabi NH, et al. High-dose dexamethasone in quinine-treated patients with cerebral malaria: a double-blind, placebo-controlled trial. J Infect Dis. 1988;158(2):325-331.
92. Meduri GU, Golden E, Freire AX, et al. Methylprednisolone infusion in early severe ARDS results of a randomized controlled trial. 2007. Chest. 2009;136(suppl 5):e30.
93. Foster JR. Steroids for early acute respiratory distress syn drome: critical appraisal of Meduri GU, Golden E, Freire AX, et al: Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 2007;131:954-963. Pediatr Crit Care Med. 2010;11(3):404-407.
94. Briel M, Meade M, Mercat A, et al. Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA. 2010;303(9):865-873.
95. Lamontagne F, Briel M, Guyatt GH, Cook DJ, Bhatnagar N, Meade M. Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome, and severe pneumonia: a meta-analysis of randomized controlled trials. J Crit Care. 2010;25(3):420-435.
96. Putensen C, Theuerkauf N, Zinserling J, Wrigge H, Pelosi P. Meta-analysis: ventilation strategies and outcomes of the acute respiratory distress syndrome and acute lung injury. Ann Intern Med. 2009;151(8):566-576.
97. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 2008;34(1):17-60.
98. Ponsford MJ, Medana IM, Prapansilp P, et al. Sequestration and microvascular congestion are associated with coma in human cerebral malaria. J Infect Dis. 2012;205(4):663-671.
99. Gattinoni L, Tognoni G, Pesenti A, et al;Prone-Supine Study Group. Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med. 2001;345(8):568-573.
100. Brodie D, Bacchetta M. Extracorporeal membrane oxygenation for ARDS in adults. N Engl J Med. 2011;365(20):1905-1914.
101. Davis TM, Krishna S, Looareesuwan S, et al. Erythrocyte sequestration and anemia in severe falciparum malaria. Analysis of acute changes in venous hematocrit using a simple mathematical model. J Clin Invest. 1990;86(3):793-800.
102. Sitprija V, Napathorn S, Laorpatanaskul S, et al. Renal and systemic hemodynamics, in falciparum malaria. Am J Nephrol. 1996;16(6):513-519.
103. Malloy JP, Brooks MH, Barry KG. Pathophysiology of acute falciparum malaria. II. Fluid compartmentalization. Am J Med. 1967;43(5):745-750.
104. Bruneel F, Gachot B, Timsit JF, et al. Shock complicating severe falciparum malaria in European adults. Intensive Care Med. 1997;23(6):698-701.
105. Maitland K, Kiguli S, Opoka RO, et al; FEAST Trial Group. Mortality after fluid bolus in African children with severe infection. N Engl J Med. 2011;364(26):2483-2495.
106. Martin GS, Moss M, Wheeler AP, Mealer M, Morris JA, Bernard GR. A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med. 2005;33(8):1681-1687.
107. Wiedemann HP, Wheeler AP, Bernard GR, et al;National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354(24):2564-2575.
108. O'Dempsey TJ, McArdle TF, Laurence BE, Lamont AC, Todd JE, Greenwood BM. Overlap in the clinical features of pneumonia and malaria in African children. Trans R Soc Trop Med Hyg. 1993;87(6):662-665.
109. English M, Punt J, Mwangi I, McHugh K, Marsh K. Clinical overlap between malaria and severe pneumonia in Africa children in hospital. Trans R Soc Trop Med Hyg. 1996;90(6):658-662.
110. Taylor WR, Cañon V, White NJ. Pulmonary manifestations of malaria: recognition and management. Treat Respir Med. 2006;5(6):419-428.
111. Bruneel F, Hocqueloux L, Alberti C, et al. The clinical spectrum of severe imported falciparum malaria in the intensive care unit: report of 188 cases in adults. Am J Respir Crit Care Med. 2003;167(5):684-689.
112. Berkley J, Mwarumba S, Bramham K, Lowe B, Marsh K. Bacteraemia complicating severe malaria in children. Trans R Soc Trop Med Hyg. 1999;93(3):283-286.
113. Berkley JA, Bejon P, Mwangi T, et al. HIV infection, malnutrition, and invasive bacterial infection among children with severe malaria. Clin Infect Dis. 2009;49(3):336-343.
114. Nadjm B, Amos B, Mtove G, et al. WHO guidelines for antimicrobial treatment in children admitted to hospital in an area of intense Plasmodium falciparum transmission: prospective study. BMJ. 2010;340:c1350.
115. Berkley JA, Maitland K, Mwangi I, et al. Use of clinical syndromes to target antibiotic prescribing in seriously ill children in malaria endemic area: observational study. BMJ. 2005;330(7498):995.
116. Bronzan RN, Taylor TE, Mwenechanya J, et al. Bacteremia in Malawian children with severe malaria: prevalence, etiology, HIV coinfection, and outcome. J Infect Dis. 2007;195(6):895-904.
117. Maude RJ, Hoque G, Hasan MU, et al. Timing of enteral feeding in cerebral malaria in resource-poor settings: a randomized trial. PLoS ONE. 2011;6(11):e27273.